Category: epilepsy

Cenobamate (ONTOZRY®) now available in The Netherlands

Angelini Pharma, an international pharmaceutical company part of the privately held Italian Angelini Group announced on 4 April 2022 that ONTOZRY® (cenobamate) is now available in the Netherlands for the adjunctive treatment of focal-onset seizures with or without secondary generalisation in adults patients who have not been adequately controlled despite an history of treatment with…

Funding boost for AI-based epilepsy monitoring

University spinout company Neuronostics has received funding to develop its BioEP platform, an AI-based system for faster, more accurate diagnosis of epilepsy and to monitor response to treatment with anti-epileptic drugs (AEDs).  BioEP works by creating mathematical models of the brain using short segments of electroencephalogram (EEG) recordings. Computer simulations rapidly reveal the ease with…

Epilepsy Research UK and Young Epilepsy – Joint Fellowship

Epilepsy Research UK (ERUK) and Young Epilepsy announce Joint Fellowship This unique research collaboration aims to improve epilepsy treatment for young people by addressing the causes, prevention and clinical management of childhood epilepsies.There are approximately 112,000 children and young people with epilepsy in the UK. Epilepsies that start in childhood can be linked with significant…